Advertisement
Screener

FENNEC PHARMACEUTICALS INC. (FENC) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

FENNEC PHARMACEUTICALS INC. Stock-Based Compensation

FENNEC PHARMACEUTICALS INC. (FENC) reported Stock-Based Compensation of $2.76 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-13

  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.77M, a 18.74% increase year-over-year.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $990.00K, a 24.06% increase year-over-year.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $2.52M, a 124.38% increase year-over-year.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $2.22M, a 21.86% increase year-over-year.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $7.03M, a 38.96% increase from fiscal 2024.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $5.06M, a 5.47% decline from fiscal 2023.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $5.35M, a 31.00% increase from fiscal 2022.
  • FENNEC PHARMACEUTICALS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $4.09M, a 9.02% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 178 monthShare-based Payment Arrangement, Noncash Expense 181 monthShare-based Payment Arrangement, Noncash Expense 184 monthShare-based Payment Arrangement, Noncash Expense 187 monthShare-based Payment Arrangement, Noncash Expense 190 monthShare-based Payment Arrangement, Noncash Expense 193 monthShare-based Payment Arrangement, Noncash Expense 196 monthShare-based Payment Arrangement, Noncash Expense 199 monthShare-based Payment Arrangement, Noncash Expense 202 monthShare-based Payment Arrangement, Noncash Expense 205 monthShare-based Payment Arrangement, Noncash Expense 208 monthShare-based Payment Arrangement, Noncash Expense 211 monthShare-based Payment Arrangement, Noncash Expense 214 monthShare-based Payment Arrangement, Noncash Expense 217 month
2026-06-30$1.77M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$2.76M
10-Q · filed 2026-08-13
$5.29M
derived: sum of 3 quarters · filed 2026-08-13
$7.50M
derived: sum of 4 quarters · filed 2026-08-13
2026-03-31$990.00K
10-Q · filed 2026-05-14
$3.51M
derived: sum of 2 quarters · filed 2026-05-14
$5.73M
derived: sum of 3 quarters · filed 2026-05-14
$7.22M
derived: sum of 4 quarters · filed 2026-08-13
2025-12-31$2.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$4.74M
derived: sum of 2 quarters · filed 2026-03-27
$6.24M
derived: sum of 3 quarters · filed 2026-08-13
$7.03M
10-K · filed 2026-03-27
2025-09-30$2.22M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$3.71M
derived: sum of 2 quarters · filed 2026-08-13
$4.51M
10-Q · filed 2025-11-13
$5.63M
derived: sum of 4 quarters · filed 2026-08-13
2025-06-30$1.49M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13
$2.29M
10-Q · filed 2026-08-13
$3.42M
derived: sum of 3 quarters · filed 2026-08-13
$5.24M
derived: sum of 4 quarters · filed 2026-08-13
2025-03-31$798.00K
10-Q · filed 2026-05-14
$1.92M
derived: sum of 2 quarters · filed 2026-05-14
$3.74M
derived: sum of 3 quarters · filed 2026-05-14
$4.67M
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
$2.94M
derived: sum of 2 quarters · filed 2026-03-27
$3.87M
derived: sum of 3 quarters · filed 2026-03-27
$5.06M
10-K · filed 2026-03-27
2024-09-30$1.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13
$2.75M
derived: sum of 2 quarters · filed 2025-11-13
$3.94M
10-Q · filed 2025-11-13
$4.79M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$925.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
$2.12M
10-Q · filed 2025-08-14
$2.97M
derived: sum of 3 quarters · filed 2025-08-14
$3.84M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$1.19M
10-Q · filed 2025-05-14
$2.05M
derived: sum of 2 quarters · filed 2025-05-14
$2.91M
derived: sum of 3 quarters · filed 2025-05-14
$5.46M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$857.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$1.72M
derived: sum of 2 quarters · filed 2025-03-26
$4.26M
derived: sum of 3 quarters · filed 2025-03-26
$5.35M
10-K · filed 2025-03-26
2023-09-30$865.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
$3.41M
derived: sum of 2 quarters · filed 2024-11-08
$4.50M
10-Q · filed 2024-11-08
$5.32M
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30$2.54M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$3.63M
10-Q · filed 2024-08-13
$4.46M
derived: sum of 3 quarters · filed 2024-08-13
$6.31M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$1.09M
10-Q · filed 2024-05-14
$1.92M
derived: sum of 2 quarters · filed 2024-05-14
$3.77M
derived: sum of 3 quarters · filed 2024-05-14
$4.78M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$827.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$2.68M
derived: sum of 2 quarters · filed 2024-03-29
$3.69M
derived: sum of 3 quarters · filed 2024-03-29
$4.09M
10-K · filed 2024-03-29
2022-09-30$1.85M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$2.86M
derived: sum of 2 quarters · filed 2023-11-09
$3.26M
10-Q · filed 2023-11-09
$4.18M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.01M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07
$1.41M
10-Q · filed 2023-08-07
$2.33M
derived: sum of 3 quarters · filed 2023-08-07
$3.24M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$399.00K
10-Q · filed 2023-05-12
$1.32M
derived: sum of 2 quarters · filed 2023-05-12
$2.23M
derived: sum of 3 quarters · filed 2023-05-12
$3.56M
derived: sum of 4 quarters · filed 2023-05-12
2021-12-31$919.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$1.84M
derived: sum of 2 quarters · filed 2023-03-29
$3.16M
derived: sum of 3 quarters · filed 2023-03-29
$3.75M
10-K · filed 2023-03-29
2021-09-30$917.00K
10-Q · filed 2021-11-10
$2.24M
derived: sum of 2 quarters · filed 2021-11-10
$2.83M
10-Q · filed 2022-11-14
$3.47M
derived: sum of 4 quarters · filed 2022-05-12
2021-06-30$1.33M
10-Q · filed 2021-08-10
$1.91M
10-Q · filed 2022-08-12
$2.55M
derived: sum of 3 quarters · filed 2022-05-12
$3.79M
derived: sum of 4 quarters · filed 2022-05-12
2021-03-31$587.00K
10-Q · filed 2022-05-12
$1.23M
derived: sum of 2 quarters · filed 2022-05-12
$2.46M
derived: sum of 3 quarters · filed 2022-05-12
$2.99M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$640.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28
$1.88M
derived: sum of 2 quarters · filed 2022-02-28
$2.40M
derived: sum of 3 quarters · filed 2022-02-28
$2.79M
10-K · filed 2022-02-28
2020-09-30$1.24M
10-Q · filed 2021-11-10
$1.76M
derived: sum of 2 quarters · filed 2021-11-10
$2.15M
10-Q · filed 2021-11-10
$2.61M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$522.00K
10-Q · filed 2021-08-10
$913.00K
10-Q · filed 2021-08-10
$1.37M
derived: sum of 3 quarters · filed 2021-08-10
$1.69M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$391.00K
10-Q · filed 2021-05-13
$852.00K
derived: sum of 2 quarters · filed 2021-05-13
$1.17M
derived: sum of 3 quarters · filed 2021-05-13
$2.83M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$461.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$775.00K
derived: sum of 2 quarters · filed 2021-03-30
$2.44M
derived: sum of 3 quarters · filed 2021-03-30
$2.67M
10-K · filed 2021-03-30
2019-09-30$314.00K
10-Q · filed 2020-11-16
$1.98M
derived: sum of 2 quarters · filed 2020-11-16
$2.20M
10-Q · filed 2020-11-16
$2.43M
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$1.67M
10-Q · filed 2020-08-05
$1.89M
10-Q · filed 2020-08-05
$2.11M
derived: sum of 3 quarters · filed 2020-08-05
$2.33M
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$221.00K
10-Q · filed 2020-05-14
$443.00K
derived: sum of 2 quarters · filed 2020-05-14
$665.00K
derived: sum of 3 quarters · filed 2020-05-14
$1.87M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31$222.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14
$444.00K
derived: sum of 2 quarters · filed 2020-02-14
$1.65M
derived: sum of 3 quarters · filed 2020-02-14
$1.82M
10-K · filed 2020-02-14
2018-09-30$222.00K
10-Q · filed 2019-11-12
$1.43M
derived: sum of 2 quarters · filed 2019-11-12
$1.60M
10-Q · filed 2019-11-12
$1.71M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.21M
10-Q · filed 2019-08-09
$1.38M
10-Q · filed 2019-08-09
$1.49M
derived: sum of 3 quarters · filed 2019-08-09
$2.40M
derived: sum of 4 quarters · filed 2019-08-09
2018-03-31$174.00K
10-Q · filed 2019-05-10
$282.00K
derived: sum of 2 quarters · filed 2019-05-10
$1.19M
derived: sum of 3 quarters · filed 2019-05-10
$1.65M
derived: sum of 4 quarters · filed 2019-05-10
2017-12-31$108.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
$1.01M
derived: sum of 2 quarters · filed 2019-03-15
$1.48M
derived: sum of 3 quarters · filed 2019-03-15
$1.52M
10-K · filed 2019-03-15
2017-09-30$907.00K
10-Q · filed 2018-11-13
$1.37M
derived: sum of 2 quarters · filed 2018-11-13
$1.41M
10-Q · filed 2018-11-13
$1.87M
derived: sum of 4 quarters · filed 2018-11-13
2017-06-30$461.00K
10-Q · filed 2018-08-13
$502.00K
10-Q · filed 2018-08-13
$965.00K
derived: sum of 3 quarters · filed 2018-08-13
$1.01M
derived: sum of 4 quarters · filed 2018-08-13
2017-03-31$41.00K
10-Q · filed 2018-05-14
$504.00K
derived: sum of 2 quarters · filed 2018-05-14
$545.00K
derived: sum of 3 quarters · filed 2018-05-14
$656.00K
derived: sum of 4 quarters · filed 2018-05-14
2016-12-31$463.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28
$504.00K
derived: sum of 2 quarters · filed 2018-03-28
$615.00K
derived: sum of 3 quarters · filed 2018-03-28
$615.00K
10-K · filed 2018-03-28
2016-09-30$41.00K
10-Q · filed 2017-11-13
$152.00K
derived: sum of 2 quarters · filed 2017-11-13
$152.00K
10-Q · filed 2017-11-13
$221.00K
derived: sum of 4 quarters · filed 2017-11-13
2016-06-30$111.00K
10-Q · filed 2017-08-14
$111.00K
10-Q · filed 2017-08-14
$180.00K
derived: sum of 3 quarters · filed 2017-08-14
$189.00K
derived: sum of 4 quarters · filed 2017-08-14
2016-03-31$0.00
10-Q · filed 2017-05-12
$69.00K
derived: sum of 2 quarters · filed 2017-05-12
$78.00K
derived: sum of 3 quarters · filed 2017-05-12
$88.00K
derived: sum of 4 quarters · filed 2017-05-12
2015-12-31$69.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29
$78.00K
derived: sum of 2 quarters · filed 2017-03-29
$88.00K
derived: sum of 3 quarters · filed 2017-03-29
$97.00K
10-K · filed 2017-03-29
2015-09-30$9.00K
10-Q · filed 2016-11-14
$19.00K
derived: sum of 2 quarters · filed 2016-11-14
$28.00K
10-Q · filed 2016-11-14
$116.00K
derived: sum of 4 quarters · filed 2016-11-14
2015-06-30$10.00K
10-Q · filed 2016-08-12
$19.00K
10-Q · filed 2016-08-12
$107.00K
derived: sum of 3 quarters · filed 2016-08-12
$174.00K
derived: sum of 4 quarters · filed 2016-08-12
2015-03-31$9.00K
10-Q · filed 2016-05-12
$97.00K
derived: sum of 2 quarters · filed 2016-05-12
$164.00K
derived: sum of 3 quarters · filed 2016-05-12
$503.00K
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31$88.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28
$155.00K
derived: sum of 2 quarters · filed 2016-03-28
$494.00K
derived: sum of 3 quarters · filed 2016-03-28
$627.00K
10-K · filed 2016-03-28
2014-09-30$67.00K
10-Q · filed 2015-11-12
$406.00K
derived: sum of 2 quarters · filed 2015-11-12
$539.00K
10-Q · filed 2015-11-12
$504.00K
derived: sum of 4 quarters · filed 2015-11-12
$10.87M
10-Q · filed 2014-11-13
2014-06-30$339.00K
10-Q · filed 2015-08-11
$472.00K
10-Q · filed 2015-08-11
$437.00K
derived: sum of 3 quarters · filed 2015-08-11
$478.00K
derived: sum of 4 quarters · filed 2015-08-11
$10.80M
10-Q · filed 2014-08-11
2014-03-31$133.00K
10-Q · filed 2015-05-15
$98.00K
derived: sum of 2 quarters · filed 2015-05-15
$139.00K
derived: sum of 3 quarters · filed 2015-05-15
$168.00K
derived: sum of 4 quarters · filed 2015-05-15
$10.46M
10-Q · filed 2014-05-15
2013-12-31-$35.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31
$6.00K
derived: sum of 2 quarters · filed 2015-03-31
$35.00K
derived: sum of 3 quarters · filed 2015-03-31
$62.00K
10-K · filed 2015-03-31
$10.33M
10-K · filed 2014-03-31
2013-09-30$41.00K
10-Q · filed 2014-11-13
$70.00K
derived: sum of 2 quarters · filed 2014-11-13
$97.00K
10-Q · filed 2014-11-13
$227.00K
derived: sum of 4 quarters · filed 2014-11-13
$10.34M
10-Q · filed 2013-11-18
2013-06-30$29.00K
10-Q · filed 2014-08-11
$29.00K
10-Q · filed 2014-08-11
$186.00K
derived: sum of 3 quarters · filed 2014-08-11
$186.00K
derived: sum of 4 quarters · filed 2014-08-11
$10.30M
10-Q · filed 2013-08-09
2013-03-31$0.00
10-Q · filed 2014-05-15
$157.00K
derived: sum of 2 quarters · filed 2014-05-15
$157.00K
derived: sum of 3 quarters · filed 2014-05-15
$174.00K
derived: sum of 4 quarters · filed 2014-05-15
$10.27M
10-Q · filed 2013-05-13
2012-12-31$157.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$157.00K
derived: sum of 2 quarters · filed 2014-03-31
$174.00K
derived: sum of 3 quarters · filed 2014-03-31
$174.00K
10-K · filed 2014-03-31
$10.27M
10-K · filed 2013-04-01
2012-09-30$0.00
10-Q · filed 2013-11-18
$17.00K
derived: sum of 2 quarters · filed 2013-11-18
$17.00K
10-Q · filed 2013-11-18
$17.00K
derived: sum of 4 quarters · filed 2013-11-18
$10.11M
10-Q · filed 2012-11-14
2012-06-30$17.00K
10-Q · filed 2013-08-09
$17.00K
10-Q · filed 2013-08-09
$17.00K
derived: sum of 3 quarters · filed 2013-08-09
$146.00K
derived: sum of 4 quarters · filed 2013-08-09
$10.11M
10-Q · filed 2012-08-13
2012-03-31$0.00
10-Q · filed 2013-05-13
$0.00
derived: sum of 2 quarters · filed 2013-05-13
$129.00K
derived: sum of 3 quarters · filed 2013-05-13
$129.00K
derived: sum of 4 quarters · filed 2013-05-13
$10.10M
10-Q · filed 2012-05-15
2011-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-01
$129.00K
derived: sum of 2 quarters · filed 2013-04-01
$129.00K
derived: sum of 3 quarters · filed 2013-04-01
$129.00K
10-K · filed 2013-04-01
$10.10M
10-K · filed 2012-03-27
2011-09-30$129.00K
10-Q · filed 2012-11-14
$129.00K
derived: sum of 2 quarters · filed 2012-11-14
$129.00K
10-Q · filed 2012-11-14
$129.00K
derived: sum of 4 quarters · filed 2012-11-14
$10.10M
10-Q · filed 2011-11-14
2011-06-30$0.00
10-Q · filed 2012-08-13
$0.00
10-Q · filed 2012-08-13
$0.00
derived: sum of 3 quarters · filed 2012-08-13
$386.00K
derived: sum of 4 quarters · filed 2012-08-13
$9.96M
10-Q · filed 2011-08-15
2011-03-31$0.00
10-Q · filed 2012-05-15
$0.00
derived: sum of 2 quarters · filed 2012-05-15
$386.00K
derived: sum of 3 quarters · filed 2012-05-15
$2.44M
derived: sum of 4 quarters · filed 2012-05-15
2010-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
$386.00K
derived: sum of 2 quarters · filed 2012-03-27
$2.44M
derived: sum of 3 quarters · filed 2012-03-27
$2.44M
10-K · filed 2012-03-27
2010-09-30$386.00K
10-Q · filed 2011-11-14
$2.44M
derived: sum of 2 quarters · filed 2011-11-14
$2.44M
10-Q · filed 2011-11-14
2010-06-30$2.05M
10-Q · filed 2011-08-15
$2.05M
10-Q · filed 2011-08-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
AGENUS INC (AGEN)United States$0.383B1.41
Surrozen, Inc./DE (SRZN)United States$0.395B
Zura Bio Ltd (ZURA)$0.398B-6.56
Ocugen, Inc. (OCGN)United States$0.343B-6.34
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60